Engineers Gate Manager’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Engineers Gate Manager’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,100	Closed	-$129K	–	2093
2020 Q1	$129K	Sell	18,100 -13,863	-43%	-$173K	0.01%	1364
2019 Q4	$763K	Buy	+31,963	New	+$882K	0.03%	781
2019 Q2	–	Sell	-19,275	Closed	-$669K	–	1474
2019 Q1	$669K	Buy	+19,275	New	+$556K	0.04%	542

Other funds holding PTLA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Engineers Gate Manager's PTLA Position: Q2 2020 in Review

Engineers Gate Manager sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 18,100 shares — an estimated $129K sold.

Engineers Gate Manager first reported a position in PTLA in Q1 2019 and held it in 3 quarters. The position peaked at $763K in Q4 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Engineers Gate Manager reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Engineers Gate Manager sold 18,100 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $129K.
Engineers Gate Manager first reported a position in Portola Pharmaceuticals, Inc. in Q1 2019 and held it in 3 quarters.
Engineers Gate Manager's Portola Pharmaceuticals, Inc. position peaked at $763K in Q4 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Engineers Gate Manager's 13F filing for Q2 2020, filed 17 Aug 2020.